Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pyxis Oncology, Inc. - Common Stock
(NQ:
PYXS
)
3.730
-0.020 (-0.53%)
Streaming Delayed Price
Updated: 10:38 AM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pyxis Oncology, Inc. - Common Stock
< Previous
1
2
3
Next >
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
July 07, 2026
Via
Chartmill
Top stock movements in today's session.
↗
July 07, 2026
Via
Chartmill
Curious about the stocks that are showing activity after the closing bell on Friday?
↗
January 09, 2026
Via
Chartmill
Unusual volume stocks in Tuesday's session
↗
December 23, 2025
Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
Pyxis Oncology: Q4 Earnings Insights
↗
March 21, 2024
Via
Benzinga
Top movers in Thursday's session
↗
December 18, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Keep an eye on the top gainers and losers in Thursday's session.
↗
December 18, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
December 18, 2025
In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Discover the top movers in Thursday's pre-market session.
↗
December 18, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 06, 2025
Via
Benzinga
Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move
↗
December 20, 2024
Pyxis Oncology prioritizes PYX-201 with promising Phase 1 results in solid tumors, while deprioritizing PYX-106 due to resource allocation and challenges.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 21, 2024
Via
Benzinga
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
↗
November 21, 2024
Via
Benzinga
Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
↗
November 21, 2024
Via
Benzinga
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
↗
November 21, 2024
Via
Benzinga
Topics
Stocks
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
↗
November 21, 2024
Pyxis Oncology announces mixed Phase 1 PYX-201 data, collaboration with Merck, and analyst downgrade citing limited efficacy beyond head-and-neck cancer.
Via
Benzinga
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside
↗
November 08, 2024
Stephens initiates coverage on Pyxis Oncology (PYXS), highlighting its promising ADC technology and a $13 price target, with upcoming clinical trial results.
Via
Benzinga
PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024
↗
August 14, 2024
PYXS stock results show that Pyxis Oncology missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
PYXS Stock Earnings: Pyxis Oncology Beats EPS, Beats Revenue for Q1 2024
↗
May 14, 2024
PYXS stock results show that Pyxis Oncology beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
↗
April 03, 2024
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
3 Biotech Stocks to Buy on the Dip: March 2024
↗
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
March 22, 2024
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion
Via
Benzinga
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 21, 2024
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via
Benzinga
PYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023
↗
March 21, 2024
PYXS stock results show that Pyxis Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
↗
March 19, 2024
These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
March 15, 2024
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
↗
February 22, 2024
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
↗
December 29, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
